Strategic Advisory Group of Experts on Immunization (SAGE) - April 2016

Background documents

Meeting of the Strategic Advisory Group of Experts on immunization, October 2015 – conclusions and Recommendations

SAGE tracking record of recommendations and action points

Immunization highlights 2015

69th World Health Assembly. Provisional agenda item 15.2 Global vaccine action plan: Report by the Secretariat

WHO vision and mission in immunization and vaccines: 2015-2030

WHO Microarray Patch product Development Workshop, Geneva, 8 December 2015: Executive summary

Public consultation on ideas for potential platforms to support development and production of health technologies for priority infectious diseases

Statement from the Ministerial Conference on Immunization in Africa in March 2016

Twenty-Ninth Inter-country Meeting of National Managers of The Expanded Programme on Immunization and Sixteenth Inter-country Meeting on Measles/Rubella Control and Elimination

Presentations

Global report including key updates and challenges from regions - J.M. Okwo-Bele

Background documents

Update on the Gavi Board Meeting, 2-3 December 2015

Gavi, the Vaccine Alliance, Record of decisions, 2-3 December 2015 Board meeting

Presentations

Report from Gavi, the Vaccine Alliance-S. Berkley

Background documents

Global Advisory Committee on Vaccine Safety (GACVS), 2-3 December 2015.

Presentations

Report of the Global Advisory Committee on Vaccine Safety (GACVS) - R. Pless

Background documents

Higgins D et al. Advances in RSV Vaccine Research and Development - A Global Agenda

Modjarrad K et al. WHO consultation on Respiratory Syncytial Virus Vaccine Development Report from a World Health Organization Meeting held on 23–24 March 2015. Vaccine 2016.

Presentations

Summary of global epidemiology and disease burden estimates for RSV - H. Nair

Background to RSV active/passive immunization development, and status of leading candidates - R. Karron

WHO consultations in 2015-2016 on RSV active/passive immunization - V. Moorthy

Background documents

SAGE Polio WG - notes from January 2016 meeting

SAGE Polio WG - notes from 3 March 2016 teleconference

An interim meeting of the mini India Expert Advisory Group (IEAG) for Polio Eradication, February 2016

IPV and the OPV switch: risk mitigation

Polio vaccines: WHO position paper – March, 2016

SAGE discussion and statement in relation with the IPV supply situation

Anand et al. Early priming with inactivated poliovirus vaccine (IPV) and intradermal fractional dose IPV administered by a microneedle device: A randomized controlled trial. Vaccine 33 (2015) 6816–6822

Resik et al. Priming after a Fractional Dose of Inactivated Poliovirus Vaccine. N Engl J Med 2013;368:416-24

Presentations

Objective of the session and overview of Global Polio Eradication Initiative - M. Zaffran

Updates on implementation of OPV2 withdrawal - D. Chang-Blanc

Report from SAGE Working Group on polio - Y. AL-Mazrou

Background documents

Concept note

Presentations

Introduction of the session - N. Turner

Presentation on the role of HSS in achieving sustainable and effective impact including achieving economies of scale and improved quality and greater equity of coverage - M.P.Kieny

Presentation of selected topics on implementation programme design including integrated supply chain management, quality data on service delivery and coordinated planning of services and examples of fragile states - H. Karamagi

Background documents

Pre-empting and responding to vaccine supply shortages. Executive Summary

WHO Executive Board 138th Session. Addressing the global shortages of medicines, and the safety and accessibility of children’s medication

ECDC Rapid Risk Assessment. Shortage of acellular pertussis - containing vaccines and impact on immunisation programmes in the EU/EEA (first update). 2 February 2016

68th World Health Assembly. Global vaccine action plan. 2015

Presentations

Introduction - CA. Siegrist

Impact of shortages and solutions set up by countries - O. Benes

Vaccine shortages: Improving cooperation, communication and management in the European Union - M. Sulzner

Global operational procurement planning and long-term strategic supply security - A. Ottosen

Conclusion and discussion

Background documents

Orientation on documents inserted for the session

WHO (2016). Global Planning Guide for Assessing and Reducing Missed Opportunities

Hutchins, et al. Studies of missed opportunities for immunization in developing and industrialized countries. Bulletin of the World Health Organization, 1993

Sridhar, et al. A systematic literature review of missed opportunities for immunization in low- and middle-income countries. Vaccine 2014

Presentations

Introduction - C. Wiysonge

Results of two country missed opportunities for vaccination assessments in Africa - R. Mihigo

Status of missed opportunities for vaccination assessments in the Americas - M. Velandia

WHO Global Plan of Action for Improving Coverage and Equity by Scaling Up Missed Opportunities Interventions - I. Ogbuanu

Background documents

Establishing a 2nd year of life health child visits as a platform for vaccination and other health interventions (2YL)

Presentations

Introduction - J. Jawad

Activities towards developing guidance for a Second-Year-of-Life (2YL) healthy child visit - R. Eggers

Findings of the Zambia 2YL case study - R. Fields, John Snow

Landscape analysis on 2YL - I. Mirza

Background documents

Background paper on dengue vaccines prepared by the SAGE working group on dengue vaccines and the WHO secretariat

Flasche S. et al. Comparative modelling of dengue vaccine public health impact (CMDVI).

Presentations

Introduction - J. Farrar

Dengue vaccine clinical trial results - P. Smith

Comparative modelling of dengue vaccine impact - N. Ferguson

Dengue Vaccines Working Group assessment and proposed recommendations - T. Nolan